Clinical Trial Update: Efficacy of Intermittent Tiotropium in Early Childhood Wheezing [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intermittent tiotropium for wheezing in early childhood was terminated. Results have been posted (2024-09-19).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Spiriva (tiotropium bromide) (tiotropium bromide)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Wheezy Bronchitis, Asthmatic Bronchitis | Phase 4 | Status: TERMINATED | Results posted: 2024-09-19